526 related articles for article (PubMed ID: 15117925)
41. Extended-spectrum beta-lactamase-producing organisms.
Falagas ME; Karageorgopoulos DE
J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
43. In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011.
Hoban DJ; Badal R; Bouchillon S; Hackel M; Kazmierczak K; Lascols C; Hawser S
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):367-72. PubMed ID: 24813688
[TBL] [Abstract][Full Text] [Related]
44. Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
Jaskulski MR; Medeiros BC; Borges JV; Zalewsky R; Fonseca ME; Marinowic DR; Rocha MP; Nodari P; Machado DC
Int J Antimicrob Agents; 2013 Jul; 42(1):76-9. PubMed ID: 23664677
[TBL] [Abstract][Full Text] [Related]
45. [Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains].
Paluchowska P; Skałkowska M; Spelak A; Budak A
Med Dosw Mikrobiol; 2012; 64(1):35-43. PubMed ID: 22808728
[TBL] [Abstract][Full Text] [Related]
46. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam.
Cheng NC; Liu CY; Huang YT; Liao CH; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2012 Jun; 67(6):1413-21. PubMed ID: 22345386
[TBL] [Abstract][Full Text] [Related]
47. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
Scioli C; Esposito S; Martinelli R
Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
[TBL] [Abstract][Full Text] [Related]
48. Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
Lee CH; Su LH; Lin WC; Tang YF; Liu JW
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e183-6. PubMed ID: 19800278
[TBL] [Abstract][Full Text] [Related]
49. [Conjugative transfer frequency of resistance genes from ESBL-producing Enterobacteriaceae strains isolated from patients hospitalized in pediatric wards].
Franiczek R; Dolna I; Krzyzanowska B; Szufnarowski K; Kowalska-Krochmal B; Zielińska M
Med Dosw Mikrobiol; 2006; 58(1):41-51. PubMed ID: 16871972
[TBL] [Abstract][Full Text] [Related]
50. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
[TBL] [Abstract][Full Text] [Related]
52. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
[TBL] [Abstract][Full Text] [Related]
53. Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Jean SS; Hsueh PR;
J Antimicrob Chemother; 2017 Jan; 72(1):166-171. PubMed ID: 27703058
[TBL] [Abstract][Full Text] [Related]
54. Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Prakash V; Lewis JS; Herrera ML; Wickes BL; Jorgensen JH
Antimicrob Agents Chemother; 2009 Mar; 53(3):1278-80. PubMed ID: 19124661
[TBL] [Abstract][Full Text] [Related]
55. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
[TBL] [Abstract][Full Text] [Related]
56. Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
Toh HS; Chuang YC; Huang CC; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Ko WC; Yu KW; Liu YC; Chen YS; Tang HJ; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S18-23. PubMed ID: 22749054
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
Liu PY; Shi ZY; Tung KC; Shyu CL; Chan KW; Liu JW; Wu ZY; Kao CC; Huang YC; Lin CF
J Infect Dev Ctries; 2014 Mar; 8(3):289-96. PubMed ID: 24619258
[TBL] [Abstract][Full Text] [Related]
58. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
Pottumarthy S; Yu Y; Sader HS; Jones RN; Chen M
Diagn Microbiol Infect Dis; 2005 Oct; 53(2):131-41. PubMed ID: 15939566
[TBL] [Abstract][Full Text] [Related]
59. [Beta-lactamases of clinical isolates of Enterobacteriaceae family].
Polishko TM; Skliar TV; Krysenko OV; Vinnikov AI; Kudriavtseva VIe
Mikrobiol Z; 2011; 73(2):20-5. PubMed ID: 21598655
[TBL] [Abstract][Full Text] [Related]
60. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
